425 results on '"Bregni, Marco"'
Search Results
2. Combined therapy targeting AR and EZH2 curbs castration-resistant prostate cancer enhancing anti-tumor T-cell response
3. On-target Toxicities Predictive of Survival in Metastatic Renal Cell Carcinoma (mRCC) Treated With Sunitinib: A Multicenter Retrospective Study
4. Cancer bio-immunotherapy XVI annual NIBIT-(Italian Network for Tumor Biotherapy) meeting, October 11–13 2018, Milan, Italy
5. Human endogenous retroviruses env gene expression and long terminal repeat methylation in colorectal cancer patients
6. Cabozantinib in Renal Cell Carcinoma With Brain Metastases: Safety and Efficacy in a Real-World Population
7. Safety and Efficacy of Cabozantinib in Metastatic Renal-Cell Carcinoma: Real-World Data From an Italian Managed Access Program
8. Anthracycline-induced cardiotoxicity: A multicenter randomised trial comparing two strategies for guiding prevention with enalapril: The International CardioOncology Society-one trial
9. Vitamin D Deficiency has a Negative Impact on Cetuximab-Mediated Cellular Cytotoxicity against Human Colon Carcinoma Cells
10. Interferon β-1a (IFNβ-1a) in COVID-19 patients (INTERCOP): study protocol for a randomized controlled trial
11. Goals and objectives of the Italian Network for Tumor Biotherapy (NIBIT)
12. Salvage High-Dose Chemotherapy for Relapsed Pure Seminoma in the Last 10 Years: Results From the European Society for Blood and Marrow Transplantation Series 2002-2012
13. Supplementary Data 3 from Castration-Induced Downregulation of SPARC in Stromal Cells Drives Neuroendocrine Differentiation of Prostate Cancer
14. Supplementary Data 1 from Castration-Induced Downregulation of SPARC in Stromal Cells Drives Neuroendocrine Differentiation of Prostate Cancer
15. Data from Castration-Induced Downregulation of SPARC in Stromal Cells Drives Neuroendocrine Differentiation of Prostate Cancer
16. uncropped western blot gels from Castration-Induced Downregulation of SPARC in Stromal Cells Drives Neuroendocrine Differentiation of Prostate Cancer
17. Supplementary Data 4 from Castration-Induced Downregulation of SPARC in Stromal Cells Drives Neuroendocrine Differentiation of Prostate Cancer
18. Supplementary Data 2 from Castration-Induced Downregulation of SPARC in Stromal Cells Drives Neuroendocrine Differentiation of Prostate Cancer
19. High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation as Adjuvant Treatment in High-Risk Breast Cancer: Data from the European Group for Blood and Marrow Transplantation Registry
20. Adjuvant High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Support for High-Risk Primary Breast Cancer: Results from the Italian National Registry
21. High-Dose Chemotherapy for Adult-Type Ovarian Granulosa Cell Tumors: A Retrospective Study of the European Society for Blood and Marrow Transplantation
22. A dual role for genetically modified lymphocytes in cancer immunotherapy
23. Cancer bio-immunotherapy XVII annual NIBIT (Italian Network for Tumor Biotherapy) meeting, October 11–13 2019, Verona, Italy
24. Prognostic role of hematologic parameters of metastatic renal cell carcinoma treated with sunitinib
25. Peripheral blood lymphocytes genetically modified to express the self/tumor antigen MAGE-A3 induce antitumor immune responses in cancer patients
26. Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I–II study
27. Human c-myc onc Gene is Located on the Region of Chromosome 8 That is Translocated in Burkitt Lymphoma Cells
28. Castration-Induced Downregulation of SPARC in Stromal Cells Drives Neuroendocrine Differentiation of Prostate Cancer
29. Tumor-mediated liver X receptor-α activation inhibits CC chemokine receptor-7 expression on dendritic cells and dampens antitumor responses
30. Prognostic role of hematologic parameters of metastatic renal cell carcinoma treated with sunitinib
31. Gene therapy for immunodeficiency due to adenosine deaminase deficiency
32. Autologous stem cell transplantation: is it still relevant in breast cancer?
33. Lymphocytes genetically modified to express tumor antigens target DCs in vivo and induce antitumor immunity
34. Allogeneic Stem Cell Transplantation for Solid Tumors: Which Way Forward?
35. Direct intramyocardial percutaneous delivery of autologous bone marrow in patients with refractory myocardial angina
36. Allogeneic stem cell transplantation for the treatment of advanced solid tumors
37. Integrated Genomic, Functional, and Prognostic Characterization of Atypical Chronic Myeloid Leukemia
38. Effectiveness and Safety of Pixantrone for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma in Every-Day Clinical Practice: The Italian Cohort of the PIXA Registry
39. Intensified Chemotherapy with Stem Cell Support for Solid Tumors in Adults: 30 Years of Investigations Can Provide Some Clear Answers?
40. Inherited perforin and Fas mutations in a patient with autoimmune lymphoproliferative syndrome and lymphoma
41. Clinical and immunologic responses in melanoma patients vaccinated with MAGE-A3-genetically modified lymphocytes
42. Therapeutic and Diagnostic Applications of Minor Histocompatibility Antigen HA-1 and HA-2 Disparities in Allogeneic Hematopoietic Stem Cell Transplantation: A Survey of Different Populations
43. Allogeneic stem cell transplantation for renal cell carcinoma
44. Interferon β-1a (IFNβ-1a) in COVID-19 patients (INTERCOP): study protocol for a randomized controlled trial.
45. Efficacy and safety of pixantrone for the treatment of multiply relapsed or refractory aggressive non‐Hodgkin B‐cell lymphomas
46. Allogeneic hematopoietic stem cell transplantation in ovarian cancer—the EBMT experience
47. Activated‐cytotoxic TCRαβ+CD4+ peripheral T‐cell lymphoma with hypodermal localization: Case report of a lymphoproliferative disorder probably evolved from the CD4+ cytotoxic T‐cell subpopulation
48. Current immunotherapy for solid tumors
49. Re: ‘A Threefold Dose Intensity Treatment With Ifosfamide, Carboplatin, and Etoposide for Patients With Small-Cell Lung Cancer: A Randomized Trial’
50. Transplantation of allogeneic hematopoietic stem cells: an emerging treatment modality for solid tumors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.